Human Interferon in Topical Therapy of Herpetic Keratitis

  • B. R. Jones
Conference paper
Part of the Internationales Symposion der Deutschen Ophthalmologischen Gesellschaft vom 12. bis 14. April 1980 in Freiburg book series (OPH.GES.)

Abstract

Dr. Sundmacher has asked me to review our experiences with interferon in topical therapy of herpetic keratitis, and I should like to present this in the light of certain other experiments that explain the evolution of this work, and indeed its slow progress. Finally, I should like to indicate my own guess as to what the future may hold in this field.

Key words

Interferon dendritic keratitis debridement 

Schlüsselwörter

Interferon Keratitis dendritica Abrasio 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Cariteli K, Hirvonen S, Mogensen KE, Pyhala L (1974) Human leucocyte interferon: production, purification, stability and animal experiments. In: Waymouth C (ed) The production and use of interferon for the treatment and prevention of human virus infections; proceedings of a Tissue Culture Association workshop, 1973. In vitro: monograph no. 3. Tissue Culture Association, Rockville Md, p 35–38Google Scholar
  2. 2.
    Cantell K, Tommila V (I960) Effect of interferon on experimental vaccinia and herpes simplex virus infections in rabbits’ eyes. Lancet 2: 682–684Google Scholar
  3. 3.
    Coster DJ, Falcon MG, Cantell K, Jones BR (1977) Clinical experience of human leucocyte interferon in rhw management of herpetic keratitis. Trans Ophthalmol Soc UK 97: 327–329PubMedGoogle Scholar
  4. 4.
    Coster DJ, Jones BR, Falcon MG (1977) Role of debridement in the treatment of herpetic keratitis. Trans Ophthalmol Soc UK 97: 314–317PubMedGoogle Scholar
  5. 5.
    Falcon MG, Jones BR (1977) Herpes simplex keratitis: animal models to guide the selection and optimal delivery of antiviral chemotherapy. J Antimicrob Chemother (suppl) 3A83–89Google Scholar
  6. 6.
    Finter NB (1973) Interferons and inducers in vivo. I. Antiviral effects in experimental animals. In: Finter NB (ed) Interferons and interferon inducers. North Holland, Amsterdam, p 295–361Google Scholar
  7. 7.
    Isaacs A, Lindenmann J (1957) Virus interference. I. The interferon. Proc Royal Society (B) 147: 258–267CrossRefGoogle Scholar
  8. 8.
    Jones BR (1967) Prospects in treating viral disease of the eye. Trans Ophthalmol Soc UK 87: 537–579PubMedGoogle Scholar
  9. 9.
    Jones BR, Al-Hussaini MK (1963) Therapeutic considerations in ocular vaccinia. Trans Ophthalmol Soc UK 83: 613–631PubMedGoogle Scholar
  10. 10.
    Jones BR, Coster DJ, Falcon MG, Cantell K (1976) Clinical trials of topical interferon therapy of ulcerative viral keratitis. Infect Dis (suppl) 133: A169–A171Google Scholar
  11. 11.
    Jones BR, Coster DJ, Falcon MG, Cantell K (1976) Topical therapy of ulcerative herpetic keratitis with human interferon. Lancet: 2: 128PubMedCrossRefGoogle Scholar
  12. 12.
    Jones BR, Coster DJ, Fison PN, Thompson GM, Cobo LM, Falcon MG (1979) Efficacy of acycloguanosine (Wellcome 248U) against herpes simplex corneal ulcers. Lancet 1: 243–244PubMedCrossRefGoogle Scholar
  13. 13.
    Jones BR, Galbraith JEK, Al-Hussaini MK (1962) Vaccinial keratitis treated with interferon. Lancet 1: 875–879PubMedCrossRefGoogle Scholar
  14. 14.
    Jones BR, Coster DJ, Michaud R, Wilhelmus KR (1980) Acyclovir in the management of herpetic keratitis. This vol.Google Scholar
  15. 15.
    Kaufman HE, Meyer RF, Laibson PR, Waltman SR, Nesburn AB, Shuster JJ (1976) Human leukocyte interferon for the prevention of recurrences of herpetic keratitis. J Infect Dis (suppl) 133A165–168CrossRefGoogle Scholar
  16. 16.
    McGill JI, Cantell K, Collins P, Finter NB, Laird R, Jones BR (1977) Optimal usage of exogenous human interferon for prevention or therapy of herpetic keratitis. Trans Ophthalmol Soc UK 97: 324–326PubMedGoogle Scholar
  17. 17.
    McGill JI, Collins P, Cantell K, Jones BR, Finter NB (1976) Optimal schedules for use of interferon in the corneas of rabbits with herpes simplex keratitis. J Infect Dis (suppl) 133: A13–A17CrossRefGoogle Scholar
  18. 18.
    Neumann-Haefelin D, Sundmacher R, Skoda R, Cantell K (1977) Comparative evaluation of human leukocyte and fibroblast interferon in the prevention of herpes simplex virus keratitis in a monkey model. Infect Immun: 468–470Google Scholar
  19. 19.
    Pallin O, Lundmark KM, Berge KG (1976) Interferon in severe herpes simplex of cornea. Lancet 1: 1187PubMedCrossRefGoogle Scholar
  20. 20.
    Patterson A, Fox AD, Davies G, Maguire CH, Sellors PJ, Wright P, Rice NSC, Cobb B, Jones BR (1963) Controlled studies of IDU in the treatment of herpetic keratitis. Trans Ophthalmol Soc UK 83: 589–591Google Scholar
  21. 21.
    Scientific Committee on Interferon. Effect of interferon on vaccination of volunteers. A report to the Medical Research Council. Lancet 1: 873–875Google Scholar
  22. 22.
    Sugar J, Kaufman HE, Varaell ED (1973) Effect of exogenous interferon on herpetic keratitis in rabbits and monkeys. Invest Ophthalmol Visual Sci 12: 378–380Google Scholar
  23. 23.
    Sundmacher R, Neumann-Haefelin D, Cantell K (1976) Interferon treatment of dendritic keratitis. Lancet 1: 1406–1407PubMedCrossRefGoogle Scholar
  24. 24.
    Sundmacher R, Neumann-Haefelin D, Cantell K (1976) Successful treatment of dendritic keratitis with human leukocyte interferon. A controlled clinical study. Albrecht von Graefes Arch Klin Ophthalmol 201: 39–45CrossRefGoogle Scholar
  25. 25.
    Tommila V (1963) Treatment of dendritic keratitis with interferon. Acta Ophthalmol (Kbh) 41: 478–482CrossRefGoogle Scholar

Copyright information

© J.F. Bergmann Verlag, München 1981

Authors and Affiliations

  • B. R. Jones
    • 1
  1. 1.LondonUK

Personalised recommendations